Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imre Noth

Showing results (191-200 of 212) with videos related to

Pageof 22
Sort By:
The Lancet. Respiratory Medicine|August 19, 2022
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association studyRichard J Allen, Justin M Oldham, David A Jenkins, et al.
American Journal of Respiratory and Critical Care Medicine|June 23, 2007
Acute exacerbations of idiopathic pulmonary fibrosisHarold R Collard, Bethany B Moore, Kevin R Flaherty, et al.
American Journal of Respiratory and Critical Care Medicine|June 9, 2026
Performance of Age-Adjusted Whole Genome Sequencing Telomere Length in Idiopathic Pulmonary FibrosisJohn S Kim, Brody Receveur, David Zhang, et al.
Science Translational Medicine|September 28, 2018
PD-1 up-regulation on CD4<sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 productionLindsay J Celada, Jonathan A Kropski, Jose D Herazo-Maya, et al.
American Journal of Respiratory and Critical Care Medicine|January 4, 2024
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory AgencyGanesh Raghu, Marya Ghazipura, Thomas R Fleming, et al.
American Journal of Respiratory and Critical Care Medicine|August 22, 2025
Associations of High Attenuation Area-related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung AbnormalitiesJohn S Kim, Catherine L Debban, Daniel Guzman, et al.
The Lancet. Respiratory Medicine|October 26, 2017
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association studyRichard J Allen, Joanne Porte, Rebecca Braybrooke, et al.
American Journal of Respiratory and Critical Care Medicine|July 25, 2019
Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary FibrosisBrian D Hobbs, Rachel K Putman, Tetsuro Araki, et al.
ERJ Open Research|October 1, 2025
Sex-specific genetic effects on susceptibility to idiopathic pulmonary fibrosisOlivia C Leavy, Anne F Goemans, Tamara Hernandez-Beeftink, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Genome-wide SNP-sex interaction analysis of susceptibility to idiopathic pulmonary fibrosisOlivia C Leavy, Anne F Goemans, Amy D Stockwell, et al.
Pageof 22

Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
The Lancet. Respiratory Medicine|August 19, 2022
Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association studyRichard J Allen, Justin M Oldham, David A Jenkins, et al.
American Journal of Respiratory and Critical Care Medicine|June 23, 2007
Acute exacerbations of idiopathic pulmonary fibrosisHarold R Collard, Bethany B Moore, Kevin R Flaherty, et al.
American Journal of Respiratory and Critical Care Medicine|June 9, 2026
Performance of Age-Adjusted Whole Genome Sequencing Telomere Length in Idiopathic Pulmonary FibrosisJohn S Kim, Brody Receveur, David Zhang, et al.
Science Translational Medicine|September 28, 2018
PD-1 up-regulation on CD4<sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 productionLindsay J Celada, Jonathan A Kropski, Jose D Herazo-Maya, et al.
American Journal of Respiratory and Critical Care Medicine|January 4, 2024
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a Symposium with Direct Engagement from Representatives of Patients, Investigators, the National Institutes of Health, a Patient Advocacy Organization, and a Regulatory AgencyGanesh Raghu, Marya Ghazipura, Thomas R Fleming, et al.
American Journal of Respiratory and Critical Care Medicine|August 22, 2025
Associations of High Attenuation Area-related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung AbnormalitiesJohn S Kim, Catherine L Debban, Daniel Guzman, et al.
The Lancet. Respiratory Medicine|October 26, 2017
Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association studyRichard J Allen, Joanne Porte, Rebecca Braybrooke, et al.
American Journal of Respiratory and Critical Care Medicine|July 25, 2019
Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary FibrosisBrian D Hobbs, Rachel K Putman, Tetsuro Araki, et al.
ERJ Open Research|October 1, 2025
Sex-specific genetic effects on susceptibility to idiopathic pulmonary fibrosisOlivia C Leavy, Anne F Goemans, Tamara Hernandez-Beeftink, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Genome-wide SNP-sex interaction analysis of susceptibility to idiopathic pulmonary fibrosisOlivia C Leavy, Anne F Goemans, Amy D Stockwell, et al.
Pageof 22